| Literature DB >> 35158689 |
Nelson Huerta-Leidenz1,2, Nancy Jerez-Timaure2,3, Argenis Rodas-González4, Jhones Onorino Sarturi1, Mindy M Brashears1, Markus F Miller1, Michel Todd Brashears1.
Abstract
The effects of castration, supplementation, and implant protocol (IP) on growth, carcass characteristics, and meat quality of grass-fed cattle were evaluated. Two experiments followed a two-way ANOVA and a 2 × 2 factorial arrangement. Experiment-I, 99 bulls were evaluated for: (a) supplementation (mineral (MS) or strategic protein-energy supplementation (SS), and (b) IP (repeated (day-0 and day-90) Zeranol-72 mg implantation (Zeranol-Zeranol) or Trenbolone Acetate-140 mg/Estradiol-20 mg (day-0) followed by Zeranol-72 mg (day-90) (TBA/E2-Zeranol). Experiment II, 50 animals were evaluated for: (a) IP (like Experiment-I), and (b) male class (steers vs. bulls). In Experiment-I, SS bulls had greater growth rate, carcass yield, and yield of high-valued boneless lean cuts than MS bulls, while decreasing (p < 0.05) time to harvest. Steaks from SS-bulls on TBA/E2-Zeranol IP were more (p = 0.05) tender than SS/Zeranol-Zeranol counterparts. Experiment-II bulls had greater growth than steers, but decreased (p < 0.05) carcass quality aspects. Zeranol-Zeranol increased (p < 0.01) meat tenderness of steers. Interactions (p < 0.05) affected cutability (Experiment-II) and meat sensory traits (Experiment-I/II). The SS improved growth, carcass yield, and shortened days until harvest of bulls, while TBA/E2-Zeranol IP positively affected tenderness in bull meat only. Castration improved carcass quality while the implant effects on cutability and tenderness were male-class dependent.Entities:
Keywords: beef; bull; carcass; cutability; grass-fed beef; palatability
Year: 2022 PMID: 35158689 PMCID: PMC8833375 DOI: 10.3390/ani12030366
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Experimental design indicating the distribution of observations (n) by breed type, male class, and implant protocol (Experiment II).
| Breed Type | Steer | Bull | Total ( | ||
|---|---|---|---|---|---|
| ZER-ZER a | TBA/E2-ZER b | ZER-ZER a | TBA/E2-ZER | ||
| F1-Angus | 1 | 2 | 3 | 3 | 9 |
| F1-Romosinuano | 3 | 2 | 3 | 3 | 11 |
| F1-Senepol | 2 | 2 | 4 | 2 | 10 |
| F1-Simmental | 1 | 2 | 4 | 3 | 10 |
| Commercial Brahman | 2 | 2 | 2 | 4 | 10 |
| Total | 9 | 10 | 16 | 15 | 50 |
a ZER-ZER: corresponds to a dose (72 mg) of zeranol at d 0 followed by a second dose (72 mg) of zeranol at d-90; b TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol 17β at d-0, followed by a second dose (72 mg) of zeranol at d-90.
Frequency distribution by fattening days according to supplementation treatment and implant protocol (Experiment I).
| Time until Harvest (Days) | SUPPL | Implant Protocol | Total | ||
|---|---|---|---|---|---|
| MS a | SS b | ZER-ZER c | TBA/E2-ZER d | ||
| 181 | 1 (7.7) | 12 (92.33) | 5 (38.5) | 8 61.5) | 13 |
| 195 | 0 (0) | 13 (100) | 7 (46.2) | 6 (46.2) | 13 |
| 209 | 5 (29.4) | 12 (70.0) | 10 (41.2) | 7 (41.2) | 17 |
| 223 | 13 (72.2) | 5 (27.8) | 7 (61.1) | 11 (61.1) | 18 |
| 237 | 21 (100) | 0 (0) | 12 (42.9) | 9 (42.9) | 21 |
| 258 | 17 (100) | 0 (0) | 9 (47.1) | 8 (47.1) | 17 |
| χ2 = 65.98; | χ2 = 2.66; | ||||
a MS: mineral supplementation designed as control treatment. b SS: strategic supplementation. c ZER-ZER: corresponds to 72 mg of zeranol at d-0 followed by a second dose (72 mg) of zeranol at d-90; d TBA/E2-ZER: corresponds to first dose containing 140 mg trenbolone acetate + 20 mg estradiol 17β at d-0, followed by a second dose (72 mg) of Zeranol (ZER) at d-90.
Growth and fabrication yield traits of bull carcasses according to supplementation and implant treatments (Experiment I).
| Variable | Supplementation | Implant Protocol | ||||||
|---|---|---|---|---|---|---|---|---|
| MS a
| SS b | ZER-ZER c | TBA/E2-ZER d | SEM | SUPPL | IMPL | SUPPL × IMPL | |
| Initial BW, kg | 347.16 | 346.90 | 344.44 | 349.7 | 2.80 | 0.96 | 0.45 | 0.88 |
| Adjusted final BW, kg e | 490.31 | 487.54 | 484.95 | 493.40 | 12.5 | 0.46 | 0.54 | 0.32 |
| Adjusted ADG f (0–d of shipment), g | 606.22 | 711.98 | 640.22 | 662.18 | 8.3 | <0.01 | 0.18 | 0.57 |
| Cold carcass weight, kg | 288.27 | 294.21 | 289.02 | 292.60 | 1.82 | 0.71 | 0.84 | 0.10 |
| Cold carcass dressing,% | 56.46 | 57.95 | 57.23 | 56.96 | 0.17 | <0.01 | 0.65 | 0.13 |
| High-valued boneless cuts, % g | 33.04 | 35.06 | 34.62 | 33.16 | 0.31 | <0.01 | 0.25 | 0.49 |
| Total clean bone,% | 7.92 | 7.71 | 7.71 | 7.76 | 0.12 | 0.50 | 0.78 | 0.72 |
| Trimmed fat,% | 3.48 | 3.80 | 3.53 | 4.02 | 0.16 | 0.83 | 0.78 | 0.91 |
a MS: mineral supplementation as a positive control. b SS: strategic supplementation. c ZER-ZER: corresponds to a dose (72 mg) of zeranol at d-0 followed by a second dose (72 mg) of Zeranol at d-90; d TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol 17β at d-0, followed by a second dose (72 mg) of zeranol at d-90. e Carcass-adjusted final BW was calculated from HCW divided by the average dressing percent across treatments and adjusted by a 4% shrink. f Carcass-adjusted ADG was calculated from carcass-adjusted final BW, initial BW, and days on a feed from 0 to d of shipment. g Tenderloin + ribeye and strip-loin + Top sirloin + Eye of round + Top (inside) round + Bottom (outside) round + knuckle + Tri-tip + Heel of round.
Cookery traits, Warner–Bratzler shear force, and trained panel ratings of bull steaks according to supplementation and implant treatments (Experiment I).
| Variable | Supplementation | Implant Protocol | ||||||
|---|---|---|---|---|---|---|---|---|
| MS a | SS b | ZER-ZER c | TBA/E2-ZER d | SEM | SUPPL | IMPL | SUPPL × IMPL | |
| Cooking loss,% | 32.44 | 34.18 | 32.86 | 33.48 | 0.29 | <0.01 | 0.16 | 0.06 |
| Cooking time, min | 79.19 | 78.37 | 77.81 | 79.90 | 0.42 | 0.07 | 0.01 | 0.11 |
| WBSF, kg e | 5.93 | 5.53 | 5.99 | 5.53 | 0.07 | <0.01 | <0.01 | 0.19 |
| Muscle fiber tenderness f | 3.91 | 4.13 | 3.91 | 4.10 | 0.06 | 0.02 | 0.04 | 0.02 |
| Amount of connective tissue g | 3.45 | 3.59 | 3.42 | 3.60 | 0.06 | 0.10 | 0.15 | <0.01 |
| Overall tenderness f | 3.50 | 3.70 | 3.51 | 3.66 | 0.06 | <0.01 | 0.32 | 0.02 |
| Juiciness h | 4.70 | 4.95 | 4.17 | 4.89 | 0.03 | 0.01 | 0.01 | 0.37 |
| Flavor intensity i | 5.77 | 5.74 | 5.75 | 5.78 | 0.02 | 0.56 | 0.66 | 0.75 |
a MS: mineral supplementation as a positive control. b SS: strategic supplementation. c ZER-ZER: corresponds to double-dose (72 mg) of zeranol at d-0 followed by a second dose (72 mg) of zeranol at d-90; d TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol benzoate at d-0, followed by a second dose (72 mg) of zeranol. e WBSF: Warner–Bratzler shear force expressed in kilograms. at d-90. f 8-point hedonic scale (1 = extremely tough, and 8 = extremely tender). g 8-point hedonic scale, (1 = abundant amount of connective tissue, and 8 = no connective tissue). h 8-point hedonic scale (1 = extremely dry, and 8 = extremely juicy). i 8-point hedonic scale (1 = extremely bland, and 8 = extremely intense).
Figure 1Mean values ± standard error for pasture supplementation (SUPPL) × implant protocol (IMPL) interaction (p = 0.02) for muscle fiber tenderness (p < 0.01; A), for connective tissue (p < 0.01 B), and overall tenderness (p = 0.02; C). Panelist ratings for bull meat (X 1 = extremely tough and 8 = extremely tender. Y 1 = abundant amount of connective tissue, 8 = no connective tissue). SUPPL: SS: strategic supplementation; MS: only mineral supplementation as a control treatment. IMPL: ZER-ZER: corresponds to a dose (72 mg) of zeranol at d-0 followed by a second identical dose at d-90; TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol 17β at d-0, followed by a second dose of zeranol (72 mg) at d-90. Bars with a common superscript lowercase letter (a, b) for IMPL treatments within the same SUPPL treatment do not differ (p > 0.05). Bars with a common superscript uppercase letter (C, D) for SUPPL treatment within the same implant treatment, do not differ (p > 0.05).
Frequency distribution by fattening days according to male class and implant protocol (Experiment II).
| Time until Harvest (Days) | Male class | Implant Protocol | Total | ||
|---|---|---|---|---|---|
| Steer | Bull | ZER-ZER a | TBA/E2-ZER b | ||
| 181 | 8 (46.7) | 8 (53.3) | 7 (46.7) | 8 (53.3) | 15 |
| 195 | 7 (41.2) | 10 (58.8) | 11 (64.7) | 6 (35.3) | 17 |
| 209 | 3 (30.0) | 7 (70.0) | 4 (40.0) | 6 (60.0) | 10 |
| 223 | 2 (28.6) | 5 (71.4) | 3 (42.9) | 4 (57.1) | 7 |
| χ2 = 1.06; | χ2 = 2.06; | ||||
a ZER-ZER: corresponds to a dose (72 mg) of zeranol at d-0 followed by a second dose (72 mg) of zeranol at d-90; b TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol 17β at d-0, followed by a second dose (72 mg) of zeranol at d-90.
Growth performance traits according to male class and implant protocol (Experiment II).
| Variable | Male Class | Implant protocol | ||||||
|---|---|---|---|---|---|---|---|---|
| Steer | Bull | ZER-ZER a | TBA/E2-ZER b | SEM | CLASS | IMPL | CLASS × IMPL | |
| Initial BW, kg | 333.78 | 348.90 | 339.16 | 346.40 | 3.75 | 0.03 | 0.36 | 0.22 |
| Muscle thickness score c | 2.15 | 2.16 | 2.16 | 2.16 | 0.08 | 0.12 | 0.16 | 0.07 |
| Frame size score d | 2.11 | 1.96 | 2.08 | 1.95 | 0.09 | 0.57 | 0.41 | 0.11 |
| Hip height, cm | 135.01 | 134.67 | 133.8 | 135.8 | 3.61 | 0.16 | 0.97 | 0.14 |
| Chronological age, mo. | 28.80 | 29.66 | 29.21 | 29.46 | 0.78 | 0.04 | 0.54 | 0.12 |
| BW at end of supplementation test, kg | 475.26 | 500.64 | 484.56 | 497.44 | 13.69 | 0.03 | 0.42 | 0.65 |
| Final BW at shipment d e, kg | 484.21 | 511.22 | 494.88 | 507.04 | 13.80 | 0.02 | 0.32 | 0.85 |
| ADG1 (0–180 d), g | 800.29 | 843.01 | 814.43 | 839.11 | 16.77 | 0.22 | 0.41 | 0.71 |
| ADG2 (0–d of shipment), g | 777.63 | 817.57 | 790.71 | 814.07 | 15.75 | 0.04 | 0.12 | 0.27 |
| Adjusted BW at shipment kg f | 464.84 | 490.77 | 475.08 | 486.75 | 14.67 | <0.01 | 0.44 | 0.73 |
| Adjusted ADG2 g, g | 677.74 | 714.42 | 689.89 | 711.07 | 4.75 | 0.18 | 0.25 | 0.45 |
| Fattening days | 195.00 | 199.52 | 197.24 | 198.36 | 5.47 | 0.07 | 0.18 | 0.15 |
a ZER-ZER: corresponds to a dose (72 mg) of zeranol at d-0 followed by a second dose (72 mg) of zeranol at d-90; b TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol 17β at d-0, followed by a second dose (72 mg) of zeranol at d-90. c 1 = very heavy muscled, and 5 = lightly muscled [40]. d 1 = very large, and 5 = very small [40]. e Shipment day was the date of loading cattle from the ranch to the abattoir after reaching the endpoint. f Carcass-adjusted final BW was calculated from HCW divided by the average dressing percent across treatments and adjusted by a 4% shrink. g Carcass-adjusted ADG2 was calculated from carcass-adjusted final BW, initial BW, and days on feed.
Carcass traits according to male class and implant protocol (Experiment II).
| Variables | Male Class | Implant Protocol | ||||||
|---|---|---|---|---|---|---|---|---|
| Steer | Bull | ZER-ZER a | TBA/E2-ZER b | SEM | CLASS | IMPL | CLASS × IMPL | |
| Hot carcass weight, kg | 285.31 | 302.74 | 293.08 | 299.16 | 3.08 | 0.02 | 0.48 | 0.86 |
| Hot carcass dressing yield,% | 58.92 | 59.23 | 59.21 | 59.01 | 0.21 | 0.64 | 0.68 | 0.94 |
| Cold carcass weight, kg | 279.61 | 296.68 | 287.21 | 293.17 | 3.02 | <0.01 | 0.21 | 0.71 |
| Cold carcass dressing yield,% | 57.74 | 58.04 | 58.03 | 57.93 | 0.20 | 0.48 | 0.63 | 0.95 |
| Conformation score c | 3.16 | 3.74 | 3.48 | 3.56 | 0.13 | <0.01 | 0.10 | 0.15 |
| Ribeye area, cm2 | 81.70 | 85.58 | 86.11 | 82.09 | 2.66 | 0.07 | 0.56 | 0.16 |
| Finish score d | 3.10 | 2.87 | 3.00 | 2.92 | 0.08 | 0.43 | 0.87 | 0.64 |
| Back-fat thickness, mm | 3.37 | 1.77 | 2.48 | 2.28 | 0.25 | <0.01 | 0.38 | 0.52 |
| Marbling score e | 4.95 | 5.48 | 5.20 | 5.36 | 0.15 | 0.03 | 0.66 | 0.80 |
| Skeletal maturity f | 177.36 | 187.42 | 178.4 | 188.8 | 5.34 | 0.21 | 0.11 | 0.73 |
| Lean maturity f | 188.42 | 214.83 | 196.0 | 213.6 | 8.89 | 0.04 | 0.07 | 0.269 |
| Overall maturity f | 183.68 | 201.29 | 186.8.0 | 202.40 | 6.81 | 0.09 | 0.08 | 0.35 |
| Adipose maturity g | 3.00 | 2.90 | 2.92 | 2.96 | 0.08 | 0.27 | 0.84 | 0.73 |
| Carcass length, cm | 130.32 | 131.84 | 130.58 | 131.84 | 3.51 | 0.06 | 0.11 | 0.46 |
| Thigh width, cm | 60.13 | 62.27 | 61.36 | 61.56 | 1.65 | 0.04 | 0.84 | 0.85 |
| Length of pelvic limb, cm | 54.97 | 57.12 | 57.21 | 55.41 | 1.58 | 0.62 | 0.16 | 0.57 |
| Leg perimeter, cm | 119.15 | 120.80 | 120.24 | 120.12 | 3.22 | 0.49 | 0.90 | 0.83 |
| Thoracic depth, cm | 36.58 | 38.30 | 37.32 | 37.99 | 1.09 | 0.64 | 0.88 | 0.49 |
a ZER-ZER: corresponds to a dose (72 mg) of zeranol at d-0 followed by a second dose (72 mg) of zeranol at d-90. b TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol 17 beta at d-0, followed by a second dose (72 mg) of zeranol at d-90. c 1 = Very convex, 2 = Convex, 3 = Rectilinear, 4 = Concave, 5 = Very concave [28]. d where, 1 = Extremely abundant, 2 = Abundant, 3 = Medium 4 = Slight, 5 = Scarce [28]. e 1 = Abundant, 2 = Moderate, 3 = Small, 4 = Slight, 5 = Traces, 6 = Practically devoid [28]. f Carcasses within the 100–199 maturity range score represents the youngest group (100 is equal to A00 and 199 is equal to A99); 200–299: represent carcasses with intermediate, more advanced maturity (200 is equal to B00 and 299 is equal to B99) [3,44]. g 1 = Ivory white, 2 = Creamy white, 3 = Light yellow, 4 = Intense yellow, 5 = Orange [3].
Frequency distribution of carcass categories/grades according to male class and implant protocol (Experiment II).
| Carcass Category/Grade | Male Class | Implant Protocol a | ||
|---|---|---|---|---|
| Steer | Bull | ZER-ZER | TBA/E2-ZER | |
| Venezuelan carcass category b | ||||
| AA | 8 (42.1) | 0 (0.0) | 5 (20) | 3 (12) |
| A | 4 (21.1) | 3 (9.7) | 4 (16) | 3 (12) |
| B | 5 (26.3) | 21 (67.7) | 13 (52) | 13 (52) |
| C | 2 (10.5) | 7 (22.6) | 3 (12) | 6 (24) |
| χ2 = 18.98; | χ2 = 1.64; | |||
| USDA Carcass Quality Grades c | ||||
| Select | 4 (21.1) | 0 (0) | 3 (12) | 1 (4) |
| High Standard | 10 (52.6) | 4 (12.9) | 7 (28) | 7 (28) |
| Low Standard | 5 (26.3) | 15 (48.4) | 9 (36) | 11 (44) |
| Bull | 0 (0) | 12 (38.7) | 6 (24) | 6 (24) |
| χ2 = 21.96; | χ2 = 1.20; | |||
| USDA Carcass Yield Grades d | ||||
| 1 | 6 (31.6) | 15 (48.4) | 10 (40) | 11 (44) |
| 2 | 2 (10.5) | 0 (0) | 1 (4) | 1 (4) |
| 3 | 11 (57.9) | 16 (51.6) | 14 (56) | 13 (52) |
| χ2 = 4.14; | χ2 = 0.080; | |||
| Total | 19 | 31 | 25 | 25 |
a ZER-ZER: corresponds to a dose (72 mg) of zeranol at d-0 followed by a second dose (72 mg) of zeranol at d-90; TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol 17β at d-0, followed by a second dose (72 mg) of zeranol at d-90. b AA, A, B, and C Venezuelan carcass categories correspond to the first, second-, third-, and fourth-quality, respectively [3]. c Carcasses of bulls younger than 30 mo. of age and (or) exhibiting an A physiological maturity are designated in the “Bullock” class; USDA Standard quality grade corresponds to the fourth quality, for bullock carcasses [44]. d USDA yield grades (YG) are rated numerically, namely, 1, 2, 3, 4, and 5; a YG 1 carcass is expected to have the highest proportion (>53.5%) of boneless, closely trimmed retail cuts, while a YG 5 carcass is expected to have the lowest proportion (<44.3%) of boneless, closely trimmed retail cuts [44].
Carcass fabrication yield traits according to male class and implant protocol (Experiment II).
| Variable | Male Class | Implant Protocol | ||||||
|---|---|---|---|---|---|---|---|---|
| Steer | Bull | ZER-ZER a
| TBA/E2-ZER b | SEM | CLASS | IMPL | CLASS × IMPL | |
| High-valued boneless cuts,% c | 34.01 | 33.26 | 33.81 | 33.28 | 0.20 | 0.31 | 0.95 | 0.35 |
| Medium-valued boneless cuts,% d | 23.66 | 25.16 | 25.07 | 25.31 | 0.32 | <0.01 | 0.01 | 0.01 |
| Low-valued cuts,% e | 21.53 | 21.33 | 21.53 | 21.29 | 0.21 | 0.29 | 0.27 | 0.28 |
| Total clean bone,% | 7.49 | 7.56 | 7.55 | 7.51 | 0.09 | 0.39 | 0.21 | 0.19 |
| Trimmed fat,% | 4.56 | 3.66 | 4.15 | 3.85 | 0.18 | <0.01 | 0.02 | <0.01 |
| Total cuts,% f | 79.21 | 80.80 | 80.40 | 79.94 | 0.31 | <0.01 | 0.17 | 0.05 |
a ZER-ZER: corresponds to a dose (72 mg) of zeranol at d-0 followed by a second dose (72 mg) of zeranol at d-90; b TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol 17β at d-0, followed by a second dose (72 mg) of zeranol at d-90. c Tenderloin + ribeye and strip-loin + Top sirloin + Eye of round + Top (inside) round + Bottom (outside) round + knuckle + Tri-tip + Heel of round. d Shoulder clod and top blade + chuck tender + chuck roll. e Brisket +Inside skirt, flank, skirts + rib plate + shanks. f Total salable products consist of the sum of the high-, medium-, and low-valued cuts. Percentages were computed based on chilled carcass weight.
Figure 2Mean values ± standard error for male class (steer, bull) × implant protocol (IMPL) interaction (p < 0.05) for percentage yield of cold carcass weight in medium-valued boneless cuts (x sum of shoulder clod and top blade + chuck tender + chuck roll) (p = 0.01; A); total (saleable) cuts (y sum of the high-, medium-, and low-valued cuts) (p = 0.05; B); and trimmed fat (p < 0.01; C). IMPL: ZER-ZER: corresponds to a dose (72 mg) of zeranol at d-0 followed by a second identical dose at d-90; TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol benzoate at d-0, followed by a second dose of zeranol (72 mg) at d-90. Bars with a common superscript lowercase letter (a, b) for IMPL treatments within the same male class do not differ (p > 0.05). Bars with a common superscript uppercase letter (C, D) for male class within the same IMPL, do not differ (p > 0.05).
Meat quality and cookery traits according to male class and implant protocol (Experiment II).
| Variables | Male Class | Implant Protocol | ||||||
|---|---|---|---|---|---|---|---|---|
| Steers | Bulls | ZER-ZER a
| TBA/E2-ZER b | SEM | CLASS | IMPL | CLASS × IMPL | |
| Cooking loss,% | 31.60 | 34.23 | 31.81 | 34.66 | 0.11 | 0.04 | <0.01 | 0.24 |
| Cooking time, min | 77.75 | 78.87 | 77.30 | 79.62 | 0.64 | 0.58 | 0.82 | 0.16 |
| WBSF, kg c | 5.52 | 5.50 | 5.29 | 5.74 | 0.29 | 0.11 | 0.04 | <0.01 |
| Muscle fiber tenderness d | 4.29 | 4.27 | 4.26 | 4.30 | 0.07 | 0.07 | 0.81 | <0.01 |
| ACT e | 3.78 | 3.75 | 3.76 | 3.75 | 0.08 | 0.87 | 0.96 | <0.01 |
| Overall tenderness d | 3.85 | 3.84 | 3.89 | 3.79 | 0.08 | 0.08 | 0.55 | <0.01 |
| Juiciness f | 4.98 | 4.97 | 4.89 | 5.07 | 0.06 | 0.05 | 0.06 | 0.14 |
| Flavor intensity g | 5.97 | 5.74 | 5.76 | 5.93 | 0.05 | 0.02 | 0.08 | 0.72 |
a ZER-ZER: corresponds to a dose (72 mg) of zeranol at d-0 followed by a second dose (72 mg) of zeranol at d-90; b TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol 17β at d-0, followed by a second dose (72 mg) of zeranol at d-90. c WBSF: Warner–Bratzler shear force. d 8-point hedonic scale, where 1 = extremely tough, and 8 = extremely tender. e ACT: Amount of connective tissue: 8-point hedonic scale, where 1 = abundant amount of connective tissue, and 8 = no connective tissue. f 8-point hedonic scale, where 1 = extremely dry, and 8 = extremely juicy. g 8-point hedonic scale, where 1 = extremely bland, and 8 = extremely intense.
Figure 3Mean values ± standard error for male class (steer, bull) × implant protocol (IMPL) interaction for muscle fiber tenderness (p < 0.01; A), amount of connective tissue (p < 0.01; B), overall tenderness (p < 0.01; C), and Warner–Bratzler shear force (WBSF, kg) (p < 0.01; D). Panelist ratings (x 1 = extremely tough and 8 = extremely tender; Y 1 = abundant amount of connective tissue, 8 = no connective tissue). IMPL: ZER-ZER: corresponds to a dose (72 mg) of zeranol at d-0 followed by a second identical dose at d-90; TBA/E2-ZER: corresponds to a first dose containing 140 mg trenbolone acetate + 20 mg estradiol benzoate at d-0, followed by a second dose of zeranol (72 mg) at d-90. Bars with a common superscript lowercase letter (a, b) for IMPL treatments within the same male class do not differ (p > 0.05). Bars with a common superscript uppercase letter (C, D) for male classes within the same IMPL, do not differ (p > 0.05).